Is hormone replacement therapy prescribed for postmenopausal diabetic women?

Area of Science:

• Endocrinology
• Cardiovascular Disease
• Women's Health

Background:

• Hormone replacement therapy (HRT) is a common treatment for menopausal symptoms.
• Diabetic women face increased cardiovascular disease (CVD) risk, a condition potentially mitigated by HRT.
• Understanding HRT prescription patterns in postmenopausal diabetic women is crucial for optimizing care.

Purpose of the Study:

• To determine current HRT prescription rates in postmenopausal women with diabetes.
• To compare HRT use in diabetic women versus women with hypertension and the general postmenopausal population.
• To identify disparities in HRT access for postmenopausal women with diabetes.

Main Methods:

• Community-based survey utilizing linked prescription data from 144,237 patients.
• Analysis focused on 6867 women aged 50-60 years.
• Comparison of HRT prescription rates across groups: general population, hypertension, and diabetes.

Main Results:

• HRT prescription rates were 24.5% in the general group, 21.8% in women with hypertension, and 11.1% in women with diabetes.
• Hypertension did not significantly affect HRT prescription likelihood (OR 0.85).
• Diabetes was associated with significantly lower HRT prescription rates (OR 0.38, p < 0.001).

Conclusions:

• Postmenopausal women with diabetes are significantly underrepresented in HRT prescriptions compared to the general population and women with hypertension.
• Diabetic women are less likely to receive HRT, potentially missing out on cardiovascular and menopausal symptom benefits.
• Clinical practice should re-evaluate HRT prescribing for postmenopausal diabetic women, considering their elevated CVD risk.